MR imaging in Spinocerebellar ataxias: A systematic review

American Journal of Neuroradiology

Volumn 37, Issue 8, 2016, Pages 1405-1412

  Klaes, A ^a   Reckziegel, E ^a   Franca, M C ^b   Rezende, T J R ^a,b,c   Vedolin, L M ^a,c   Jardim, L B ^a,c   Saute, J A ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

POLYGLUTAMINE;

ARTICLE; BRAIN ATROPHY; BRAIN STEM; CEREBELLUM VERMIS; CERVICAL SPINE; CONTROLLED CLINICAL TRIAL (TOPIC); CORPUS STRIATUM; CROSS-SECTIONAL STUDY; DENTATORUBROPALLIDOLUYSIAN ATROPHY; DIFFUSION TENSOR IMAGING; DORSAL STRIATUM; FOLLOW UP; HEMISPHERE; HUMAN; MEDULLA OBLONGATA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PONS; QUANTITATIVE ANALYSIS; SPINOCEREBELLAR DEGENERATION; SYSTEMATIC REVIEW; THALAMUS; ADULT; DIAGNOSTIC IMAGING; FEMALE; MALE; PATHOLOGY; PROCEDURES;

ADULT; FEMALE; HUMANS; MALE; NEUROIMAGING; SPINOCEREBELLAR ATAXIAS;

EID: 84982113859     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A4760     Document Type: Article

References (43)

1. Durr A. Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond. Lancet Neurol 2010;9:885-94
2. Ruano L, Melo C, Silva MC, et al. The global epidemiology of hereditary ataxia and spastic paraplegia: A systematic review of prevalence studies. Neuroepidemiology 2014;42:174-83
3. Bird TD. Hereditary ataxia overview. 1998 October 28. Updated 2015 June 11. In: Pagon RA, National Human Genome Research Institute; National Library of Medicine; University of Washington
4. National Center for Biotechnology Information; National Institutes of Health. GeneReviews. Seattle: University of Washington; 1993
5. Pedroso JL, FrançaMCJr, Braga-Neto P, et al. Nonmotor and extracerebellar features in Machado-Joseph disease: A review. Mov Disord 2013;28:1200-08
6. Rüb U, Schöls L, Paulson H, et al. Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7. Prog Neurobiol 2013;104:38-66
7. Schmitz-Hübsch T, du Montcel ST, Baliko L, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 2006;66:1717-20
8. Kieling C, Rieder CRM, Silva ACF, et al. A neurological examination score for the assessment of spinocerebellar ataxia 3 (SCA3). Eur J Neurol 2008;15:371-76
9. Schmitz-Hübsch T, Fimmers R, Rakowicz M, et al. Responsiveness of different rating instruments in spinocerebellar ataxia patients. Neurology 2010;74:678-84
10. Jardim LB, Hauser L, Kieling C, et al. Progression rate of neurological deficits in a 10-year cohort of SCA3 patients. Cerebellum 2010; 9:419-28
11. Jacobi H, Bauer P, Giunti P, et al. The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: A 2-year follow-up study. Neurology 2011;77:1035-41
12. Saute JA, Donis KC, Serrano-Munuera C, et al; Iberoamerican Multidisciplinary Network for the Study of Movement Disorders (RIB ERMOV) Study Group. Ataxia rating scales: psychometric profiles, natural history and their application in clinical trials. Cerebellum 2012;11:488-504
13. Saute JA, de Castilhos RM, Monte TL, et al. A randomized, phase 2 clinical trial of lithium carbonate in Machado-Joseph disease. Mov Disord 2014;29:568-73
14. Saute JA, Rieder CR, Castilhos RM, et al. Planning future clinical trials in Machado Joseph disease: lessons from a phase 2 trial. J Neurol Sci 2015;358:72-76
15. Saute JA, Jardim LB. Machado Joseph disease: current clinical, genetic and therapeutic issues. Expert Opin Orphan Drug 2015;5: 517-35
16. Moher D, Liberati A, Tetzlaff J, et al; PRISMA Group. Preferred reporting items for systematic reviews and meta-Analyses: The PRISMA statement. PLoS Med 2009;6:e1000097
17. DAbreu A, França MC Jr, Yasuda CL, et al. Neocortical atrophy in Machado-Joseph disease: A longitudinal neuroimaging study. J Neuroimaging 2012;22:285-91
18. Reetz K, Costa AS, Mirzazade S, et al; Ataxia Study Group Investigators. Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6. Brain 2013; 136:905-17
19. Della Nave R, Ginestroni A, Tessa C, et al. Brain structural damage in spinocerebellar ataxia type: A voxel-based morphometry study. Mov Disord 2008;23:899-903
20. Adanyeguh IM, Henry PG, Nguyen TM, et al. In vivo neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7. Mov Disord 2015;30:662-70
21. Lei L, Liao Y, Liao W, et al. Magnetic resonance spectroscopy of the cerebellum in patients with spinocerebellar ataxia type 3/Machado-Joseph disease. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2011;36: 511-19
22. Lirng JF, Wang PS, Chen HC, et al. Differences between spinocerebellar ataxias and multiple system atrophy-cerebellar type on proton magnetic resonance spectroscopy. PLoS One 2012;7:e47925
23. Wang PS, Chen HC, Wu HM, et al. Association between proton magnetic resonance spectroscopy measurements and CAG repeat number in patients with spinocerebellar ataxias 2, 3, or 6. PLoS One 2012;7:e47479
24. Xing W, Wang XY, Liao XX, et al. Spin labeling artery method perfusion MRI study of SPG4 and SCA3/MJD. Magn Reson Imaging 2014;32:1330-34
25. Guimaraes RP, DAbreu A, Yasuda CL, et al. A multimodal evaluation of microstructural white matter damage in spinocerebellar ataxia type 3. Mov Disord 2013;28:1125-32
26. DAbreu A, França M Jr, Appenzeller S, et al. Axonal dysfunction in the deep white matter in Machado-Joseph disease. J Neuroimaging 2009;19:9-12
27. Lopes TM, DAbreu A, França MC Jr, et al. Widespread neuronal damage and cognitive dysfunction in spinocerebellar ataxia type 3. J Neurol 2013;260:2370-79
28. Wang TY, Jao CW, Soong BW, et al. Change in the cortical complexity of spinocerebellar ataxia type 3 appears earlier than clinical symptoms. PLoS One 2015;10:e0118828
29. Hernandez-Castillo CR, Galvez V, Diaz R, et al. Specific cerebellar and cortical degeneration correlates with ataxia severity in spinocerebellar ataxia type 7. Brain Imaging Behav 2015 Apr 28. [Epub ahead of print] Medline
30. Schulz JB, Borkert J, Wolf S, et al. Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6. Neuroimage 2010;49:158-68
31. Jacobi H, Reetz K, du Montcel ST, et al. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: Analysis of baseline data. Lancet Neurol 2013;12:650-58
32. DAbreu A, França MC Jr, Yasuda CL, et al. Thalamic volume and dystonia in Machado-Joseph disease. J Neuroimaging 2011;21: e91-93
33. de Rezende TJ, DAbreu A, Guimaraes RP, et al. Cerebral cortex involvement in Machado-Joseph disease. Eur J Neurol 2015;22:277-83, e23-24
34. Fahl CN, Branco LM, Bergo FP, et al. Spinal cord damage in Machado-Joseph disease. Cerebellum 2015;14:128-32
35. Lam RW, Kennedy SH. Using metaanalysis to evaluate evidence: practical tips and traps. Can J Psychiatry 2005;50:167-74 Medline
36. Greeve DN. An absolute beginners guide to surface-And voxelbased morphometric analysis. Proc Intl Soc Mag Reson Med 2011;19. http://cds.ismrm.org/protected/11MProceedings/files/ISMRM2011-8410.pdf. Accessed April 7, 2016
37. Grimm O, Pohlack S, Cacciaglia R, et L. Amygdalar and hippocampal volume: A comparison between manual segmentation, Freesurfer and VBM. J Neurosci Methods 2015;253:254-61
38. Nordenskjöld R, Malmberg F, Larsson EM, et al. Intracranial volume estimated with commonly used methods could introduce bias in studies including brain volume measurements. Neuroimage 2013; 83:355-60
39. Rosas HD, Doros G, Gevorkian S, et al. PRECREST: A phase II prevention and biomarker trial of creatine in at-risk Huntington disease. Neurology 2014;82:850-57
40. Hutton C, Draganski B, Ashburner J, et al. A comparison between voxel-based cortical thickness and voxel-based morphometry in normal aging. Neuroimage 2009;48:371-80
41. Hansen TI, Brezova V, Eikenes L, et al. How does the accuracy of intracranial volume measurements affect normalized brain volumes? Sample size estimates based on 966 subjects from theHUNT MRI Cohort. AJNR Am J Neuroradiol 2015;36:1450-56
42. Desikan RS, Ségonne F, Fischl B, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 2006;31:968-80
43. Schmahmann JD, Doyon J, McDonald D, et al. Three-dimensional MRI atlas of the human cerebellum in proportional stereotaxic space. NeuroImage 1999;10:233-60